Patent · US Active

Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof

US9395354B2 · kind B2 · utility

3Cited by

13References

54Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Ning Sun · Fremont, US
Michael T. Longaker · Atherton, US
Robert C. Robbins · Stanford, US
Joseph Wu · Stanford, US
Feng Lan · Beijing, CN
Andrew S. Lee · San Jose, US
Paul W. Burridge · Chicago, US

Key dates

Filing date	Jul 20, 2012
Grant date	Jul 19, 2016
Priority date	—
Expiry date	Jul 20, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/325
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.